[go: up one dir, main page]

MX2015013739A - Potenciadores de solubilidad del agua a base de glucogeno. - Google Patents

Potenciadores de solubilidad del agua a base de glucogeno.

Info

Publication number
MX2015013739A
MX2015013739A MX2015013739A MX2015013739A MX2015013739A MX 2015013739 A MX2015013739 A MX 2015013739A MX 2015013739 A MX2015013739 A MX 2015013739A MX 2015013739 A MX2015013739 A MX 2015013739A MX 2015013739 A MX2015013739 A MX 2015013739A
Authority
MX
Mexico
Prior art keywords
glycogen
water solubility
based water
solubility enhancers
lipophilic compounds
Prior art date
Application number
MX2015013739A
Other languages
English (en)
Other versions
MX369778B (es
Inventor
Elisa Liberati
Serena Tongiani
Vincenzo Russo
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of MX2015013739A publication Critical patent/MX2015013739A/es
Publication of MX369778B publication Critical patent/MX369778B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • A23L33/155Vitamins A or D
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10General cosmetic use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

La presente invención se refiere a polímeros a base de glucógeno y el uso de los mismos para incrementar la solubilidad en agua de los compuestos lipofílicos, a complejos de estos polímeros a base de glucógeno con los compuestos lipofílicos y el uso de los mismos para administrar los compuestos lipofílicos, y a composiciones farmacéuticas nutracéuticas y cosméticas que comprenden estos complejos.
MX2015013739A 2013-04-05 2014-03-31 Potenciadores de solubilidad del agua a base de glucogeno. MX369778B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13162453 2013-04-05
PCT/EP2014/056451 WO2014161815A1 (en) 2013-04-05 2014-03-31 Glycogen-based water solubility enhancers

Publications (2)

Publication Number Publication Date
MX2015013739A true MX2015013739A (es) 2016-06-21
MX369778B MX369778B (es) 2019-11-21

Family

ID=48049850

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015013739A MX369778B (es) 2013-04-05 2014-03-31 Potenciadores de solubilidad del agua a base de glucogeno.

Country Status (27)

Country Link
US (1) US10662259B2 (es)
EP (1) EP2981557B1 (es)
JP (1) JP6312801B2 (es)
KR (1) KR102113707B1 (es)
CN (1) CN105143274B (es)
AR (1) AR095937A1 (es)
AU (1) AU2014247145B2 (es)
BR (1) BR112015024825A2 (es)
CA (1) CA2905273A1 (es)
CY (1) CY1122935T1 (es)
DK (1) DK2981557T3 (es)
EA (1) EA032500B1 (es)
ES (1) ES2786900T3 (es)
GE (1) GEP201706742B (es)
HR (1) HRP20200693T1 (es)
HU (1) HUE049561T2 (es)
IL (1) IL241690B (es)
LT (1) LT2981557T (es)
MX (1) MX369778B (es)
PL (1) PL2981557T3 (es)
PT (1) PT2981557T (es)
RS (1) RS60506B1 (es)
SG (2) SG10201708099YA (es)
SI (1) SI2981557T1 (es)
SM (1) SMT202000216T1 (es)
UA (1) UA119441C2 (es)
WO (1) WO2014161815A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2910393A1 (en) 2013-04-26 2014-10-30 Mirexus Biotechnologies Inc. Polyfunctional glycogen and phytoglycogen additives
JP6564369B2 (ja) 2013-12-09 2019-08-21 デュレクト コーポレイション 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
US11508407B2 (en) * 2018-03-30 2022-11-22 Sony Corporation Magnetic recording medium having controlled dimensional characteristics
WO2024158694A1 (en) 2023-01-23 2024-08-02 Villya LLC Compositions and methods for improving the solubility of erectile dysfunction therapeutics

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1514720A (en) * 1974-10-07 1978-06-21 Secr Defence Preparation of hydroxyethyl starch
US4228277A (en) * 1979-02-12 1980-10-14 Hercules Incorporated Modified nonionic cellulose ethers
IT1255488B (it) 1992-08-04 1995-11-06 Angelini Francesco Ist Ricerca Polisaccaridi del glicogeno
US5607839A (en) * 1993-07-22 1997-03-04 Nippon Oil Company, Ltd. Bacteria belonging to new genus process for production of carotenoids using same
US6248361B1 (en) * 1999-02-26 2001-06-19 Integ, Ltd. Water-soluble folic acid compositions
JP2005501930A (ja) * 2001-08-22 2005-01-20 スピラモール パレンテラル コロイズ ゲー・エム・ベー・ハー 哺乳動物の外科的若しくは治療的な処置方法、又は診断方法に使用、特に血漿増量剤に使用をする高度分枝アミロペクチン
DE10237442B4 (de) * 2002-08-16 2004-08-19 Fresenius Kabi Deutschland Gmbh Hochverzweigte, niedrig substituierte Stärkeprodukte
US7446101B1 (en) * 2003-12-12 2008-11-04 Bioactives, Llc Bioavailable carotenoid-cyclodextrin formulations for soft-gels and other encapsulation systems
WO2006040335A1 (en) * 2004-10-15 2006-04-20 Danisco A/S A derivatized highly branched polysaccharide and a mix for production of polyurethane thereof
US7781572B2 (en) 2005-10-05 2010-08-24 Nse Products, Inc. Nanosized carotenoid cyclodextrin complexes
US8613946B2 (en) * 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US9315715B2 (en) * 2009-10-20 2016-04-19 Nalco Company Method of reducing the viscosity of hydrocarbons
US8901092B2 (en) * 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery
LT2825565T (lt) 2012-03-15 2019-07-10 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Katijoninis polimeras glikogeno pagrindu
FR2989001B1 (fr) * 2012-04-06 2017-07-21 Centre Nat Rech Scient Microparticules et nanoparticules constituees de polysaccharides hydrophobises et d'une alpha-cyclodextrine

Also Published As

Publication number Publication date
EA032500B1 (ru) 2019-06-28
BR112015024825A2 (pt) 2017-07-18
SG10201708099YA (en) 2017-11-29
CA2905273A1 (en) 2014-10-09
HK1215955A1 (en) 2016-09-30
ES2786900T3 (es) 2020-10-14
CN105143274A (zh) 2015-12-09
IL241690B (en) 2019-05-30
SG11201507932RA (en) 2015-10-29
EA201591860A1 (ru) 2016-02-29
EP2981557B1 (en) 2020-02-05
SMT202000216T1 (it) 2020-07-08
HUE049561T2 (hu) 2020-10-28
US10662259B2 (en) 2020-05-26
AU2014247145B2 (en) 2018-03-22
PL2981557T3 (pl) 2020-10-19
HRP20200693T1 (hr) 2020-07-24
CY1122935T1 (el) 2021-10-29
LT2981557T (lt) 2020-07-27
JP6312801B2 (ja) 2018-04-18
US20160068615A1 (en) 2016-03-10
CN105143274B (zh) 2020-05-05
KR20150139877A (ko) 2015-12-14
SI2981557T1 (sl) 2020-08-31
EP2981557A1 (en) 2016-02-10
AR095937A1 (es) 2015-11-25
KR102113707B1 (ko) 2020-06-03
MX369778B (es) 2019-11-21
PT2981557T (pt) 2020-05-04
JP2016516857A (ja) 2016-06-09
DK2981557T3 (da) 2020-04-27
UA119441C2 (uk) 2019-06-25
AU2014247145A1 (en) 2015-10-08
RS60506B1 (sr) 2020-08-31
GEP201706742B (en) 2017-09-25
WO2014161815A1 (en) 2014-10-09

Similar Documents

Publication Publication Date Title
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2019013123A (es) Dosificacion oral de compuestos peptido similar al glaucon-1 (glp-1).
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
PH12015500825B1 (en) Substituted benzene compounds
MX2015008628A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
GB201209613D0 (en) New compounds
JOP20140114B1 (ar) مركبات حلقية غير متجانسة واستخداماتها
PH12015501753B1 (en) Enhanced stability of novel liquid compositions
EA201590491A1 (ru) Иммуногенная композиция
CL2015001202A1 (es) Compuestos derivados de oxazolidin-2-ona-pirimidina; composicion y combinacion farmaceutica y uso en el tratamiento del cancer.
CY1121238T1 (el) Παραγωγα παντοθενικου για την αντιμετωπιση νευρολογικων διαταραχων
CY1122935T1 (el) Ενισχυτικα της υδατοδιαλυτοτητας που βασιζονται στο γλυκογονο
PH12016500924A1 (en) Anti-cancer agents and preparation thereof
MX370990B (es) Ésteres de ácidos oligo-hidroxicarboxílicos y uso de los mismos.
NZ717192A (en) Anti-inflammatory tripeptides
GB2527233A (en) Composition comprising hydrocortisone
CY1117740T1 (el) Χρηση του odiparcil στη θεραπεια μιας μυκοπολυσακχαριδωσης
UA116011C2 (uk) Частинки фенілефрину резинату та їх використання у фармацевтичних композиціях
ES2426017A2 (es) Microemulsión que comprende colagenasa y usos
TH148804B (th) สูตรยาที่ใช้รับประทานที่ประกอบรวมด้วยลานโซพราโซล (Laxoprazole) และวิธีการเตรียมสิ่งดังกล่าว

Legal Events

Date Code Title Description
FG Grant or registration